A commercial breakthrough in the field of complex therapeutic proteins for dogs by sector leader Zoetis has roused rivals to action in a hunt for biotechnology medicines to treat pets.
Source:: Reuters – Business News
A commercial breakthrough in the field of complex therapeutic proteins for dogs by sector leader Zoetis has roused rivals to action in a hunt for biotechnology medicines to treat pets.
Source:: Reuters – Business News
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.